Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

New York State Psychiatric Institute: Clinical Trials & FDA Approval Profile

New York State Psychiatric Institute (Global / Institutional) sponsors 33 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 8 active protocols (5 recruiting now), 11 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)42.4%
Median Closed Enrollment vs National (145 pts)16 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for New York State Psychiatric Institute
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)33
Active Pipeline (Recruiting Now)8 (5)
Completed vs Stopped Early11 / 14 (42.4%)
Median Closed Actual Enrollment16 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With New York State Psychiatric Institute
Hospital Research SiteLocationShared Protocols
Columbia University Irving Medical CenterNew York, NY3

Explore interactive annual charts and M&A subsidiary rollups in the New York State Psychiatric Institute Interactive Dossier, benchmark peers in Neurology, Psychiatry, and Pain, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI